Abstract
IntroductionHere, key safety and efficacy data from the maintenance study of Upadacitinib (UPA) phase 3 clinical trial in UC are summarized.Aims and MethodsPatients with a clinical response (per Adapted Mayo...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
